While large swaths of the country are experiencing the biggest opioid epidemic on record, other parts of the country are experimenting with a new frontier of wellness: previously illegal drugs. From the rise of medical marijuana to Gwyneth Paltrow’s new health prediction (psychedelics, anyone?) here are a few of the most significant drug-related health and wellness stories from last week.
Gwyneth Paltrow Continues to Push the Boundaries
Gwyneth Paltrow, actress and founder of health and lifestyle website Goop, has her sights set on a new trend–psychedelics. In an interview she gave to the New York Times, Paltrow said that “I think how psychedelics affect health and mental health and addiction will come more into the mainstream.” While most of Paltrow’s statements set the Internet ablaze with controversy, many are saying she very well could be correct in her assumptions. After all, prize-winning author Michael Pollan, famous for his 2006 bestseller “The Omnivore’s Dilemma,” wrote a book last year titled ” How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence,” which had an accompanying media tour.
CBD’s Rocky Road
Since Colorado decriminalized marijuana back in 2014, companies have been inching their way into the growing cannabis market. Companies have been popping up in large numbers, with a few celebrities getting in on the action. Last week even Martha Stewart announced her partnership with Canopy Growth, a company specializing in CBD products for humans and for your pets! However, with the recent resignation of FDA commissioner Scott Gottlieb, CBD stocks have tumbled and led investors to question the fate of the industry. Gottlieb, who was the head of the FDA for two years, did his best to decriminalize and push regulation for CBD products.